Perform world-class research—advance our understanding of cancer genomics
Illumina next-generation sequencing (NGS) and microarray technologies represent the gold standard in quality worldwide—and account for ~90% of the world’s sequencing data.* Innovative, intuitive, and completely integrated, our sample-to-data solutions empower your lab to keep ahead of the curve in the rapidly evolving genomics revolution. So you’ll be better able to perform the world-class cancer genomics research you strive for—with the goal of uncovering new insights into the biology of cancer that can lead to meaningful advances in personalized medicine.
Our comprehensive genomics product offerings support multiple cancer research applications, including studies of DNA, RNA, epigenetics, and more. Our range of sequencers can be scaled to meet your needs—from powerful, yet personal, benchtop models to versatile, high-throughput systems. With intuitive data analysis and management capabilities and unsurpassed customer support, we can deliver the answers you seek—quickly, accurately, and cost-effectively.
Cancer Genomics Research Topics
Explore genomics-based approaches to investigating cancer using NGS and microarrays.
- Cancer Sequencing Methods
- Cancer Immunotherapy Research
- Cancer Epigenetics
- Chromosomal Abnormalities
- Products and Services
Cancer Sequencing Methods
NGS methods enable cancer researchers to perform whole-genome studies, targeted gene profiling, tumor-normal comparisons, and more. NGS also offers the sensitivity to detect rare somatic variants, tumor subclones, and circulating DNA fragments.
Cancer Immunotherapy Research
Immuno-oncology is an emerging field that has taken great strides in the fight against cancer, bolstered by a refined understanding of how tumors evade the natural immune response. Research into the mechanisms tumors use to inhibit the immune response have led to promising therapeutic targets.
Cancer Epigenetics
Changes in gene activation or gene silencing can impact the rate of cancer progression. Studying the epigenetic changes that influence gene expression can provide insight into important tumorigenic pathways.
Chromosomal Abnormalities
Genomic instability and chromosomal abnormalities are common features of cancer. Understanding these structural aberrations can inform studies of cancer etiology.
Products and Services
Illumina offers various NGS and microarray products and services to support cancer genomics research.
Redefining NGS in Cancer Research
During this webinar, our expert speakers provide background information on next-generation sequencing (NGS), discuss the achievements and challenges associated with NGS, and discuss how an integrated multiomics approach can be used in cancer diagnosis and treatment.
View Webinar
Recent Cancer Genomics Articles
Children’s Mercy Kansas City tackles the unique complexity of pediatric cancer
A new exome-based test will help determine the genetic variants—germline and somatic—driving these rare cancers
Read Article
Using Analytics to Improve Cancer Diagnosis and Therapy Selection
Developing and automating workflows for analyzing, processing, and sharing genomic data among researchers and clinicians.
Read Interview
How organizations around the world are closing the cancer care gap
On World Cancer Day, Illumina celebrates the nonprofits and institutions working hard to increase access to care
Read ArticleThe NovaSeq 6000 System
High-quality, high-coverage sequencing offers a comprehensive view of the genome to detect variants accurately, characterize isoforms, and more. With increased throughput and reduced price per sample, the NovaSeq 6000 System is ideal for data-intensive applications.
View System
Featured Products
Multiomic Sequencing Applications
10X Genomics Chromium Single Cell Multiome ATAC + Gene Expression
Unify single-cell gene expression and chromatin accessibility to help reveal cellular mechanisms driving gene regulation.
Read Tech NoteMeasure Protein Expression with RNA-Seq
Learn how to incorporate protein detection into bulk RNA-Seq and develop a workflow for BEN-Seq, providing a holistic approach to cell analysis.
Read Application NoteMaking Sense of Cancer Genomes
In this podcast episode, Drs. Obi and Malachi Griffith, Professors of Medicine at Washington University in St. Louis, MO, discuss their work in improving interpretations of sequence variants in cancer and enhancing bioinformatics education.
Listen Now
Beginner's Guide to Next-Generation Sequencing
Considering bringing next-generation sequencing to your lab, but unsure where to start? These resources cover key topics in NGS and are designed to help you plan your first experiment.
Get Started
Learn More
Cancer Research Review
An overview of recent cancer genomics research publications featuring Illumina technology.
Insights into Leukemia and Lymphoma
Munich Leukemia Laboratory is using NGS to gain a better understanding of leukemia and lymphoma subtypes and discover new therapeutic pathways.
Interested in receiving newsletters, case studies, and information on cancer genomics?
Sign Up
Educational Webinars
Explore a variety of webinars on topics ranging from cancer research to NGS data analysis, microbiome studies, and more.
2021 Cancer Research Methods Guide
This updated guide provides an overview of NGS-based and microarray workflows for a broad range of cancer research applications.
Sequencing Analysis of Tissue Samples: Fresh Frozen vs. FFPE
A researcher from Massachusetts General Hospital compares sequencing results from FFPE and fresh-frozen tumor samples.
References
*Data on file based on a 2013 study.